Efalizumab-associated papular psoriasis is a common adverse event caused by efelizumab therapy. This clinical manifestation is characterized by a transient popular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.
Antonucci A, Bardazzi F, Balestri R, Patrizi A (2009). Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases. THE JOURNAL OF DERMATOLOGICAL TREATMENT, 20, 31-62 [10.1080/09546630802206652].
Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
ANTONUCCI, ANGELA;BARDAZZI, FEDERICO;BALESTRI, RICCARDO;PATRIZI, ANNALISA
2009
Abstract
Efalizumab-associated papular psoriasis is a common adverse event caused by efelizumab therapy. This clinical manifestation is characterized by a transient popular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
